It could help patients regain movement by targeting brain rhythms.
Our current best theories of the universe suggest that dark energy is making it expand faster and faster, but new observations from the Dark Energy Spectroscopic Instrument suggest this mysterious force is actually growing weaker
It can be difficult to recall exactly when a specific event happened, and now it seems our memory can be tricked into pushing occurrences back in time, making us think they happened earlier than in reality
String theory may be our best attempt at a theory of everything, except that it can’t describe an expanding universe like ours. Now a radical new twist on the idea could finally fix that – but it requires us to completely reimagine reality
The symbols and mathematical operations used in the laws of physics follow a pattern that could reveal something fundamental about the universe
Daniele Oriti’s pursuit of a theory of quantum gravity has led him to the startling conclusion that the laws of nature don’t exist independently of us – a perspective shift that could yield fresh breakthroughs
Buy me a pint here:
https://www.subscribestar.com/morgoth-s-review.
https://www.patreon.com/Morgoth.
Buy me a coffee.
https://www.buymeacoffee.com/morgoth.
Bitchute.
https://www.bitchute.com/channel/morgothsreview/
Thanks to Theberton for the intros and outros.
https://www.youtube.com/channel/UC_0KCOY6LkteChDivbb6QBQ
Findings from the Dark Energy Spectroscopic Instrument (DESI) suggest that dark energy could be evolving over time. If they’re right, cosmology will need a.
NVIDIA today announced it is building a Boston-based research center to provide cutting-edge technologies to advance quantum computing.
Oxford BioTherapeutics (OBT) has entered a multi-year partnership with Roche to discover antibody-based therapeutics for cancer treatment.
The partnership will leverage OBT’s OGAP-Verify discovery platform, which claims to offer greater sensitivity and enables target selection with enhanced drug development attributes.
OBT has entered a multi-year partnership with Roche to discover antibody-based therapeutics for cancer treatment.